Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05338671 · ClinicalTrials.gov registry record · Phase 4
Effect of Post-Operative Anesthetics on Post-Operative Pain in Patients Receiving Endodontic Treatment
A Phase 4 study of Postoperative Pain and Endodontic Disease, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT05338671: Completed Phase 4 study of Postoperative Pain and Endodontic Disease, sponsored by University of Washington.
NCT05338671 is a Phase 4 study of Postoperative Pain and Endodontic Disease that has completed, run by University of Washington. The registered enrollment target is 35 participants, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05338671, a Phase 4 study of Postoperative Pain and Endodontic Disease, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the efficacy of two local anesthetics (2% lidocaine 1:100,000 epinephrine and 0.5% bupivicaine 1:200,000 epinephrine) in reducing post-operative pain in patients receiving endodontic treatment.
Primary Outcome
Participants will be asked to track the amount of pain they have following their endodontic treatment using the Heft-Parker visual analog scale with scores ranging from 0-170 with higher scores signifying more pain.
Conditions Studied
Interventions
- DRUG Local anesthetic
Study Locations (1)
Washington
- University of Washington- School of Dentistry - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2024-06-01 |
| Phase | Phase 4 |
What the finished NCT05338671 record still lists
NCT05338671 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which Local anesthetic is the first listed.
NCT05338671 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05338671 about?
NCT05338671 is a clinical study titled "Effect of Post-Operative Anesthetics on Post-Operative Pain in Patients Receiving Endodontic Treatment". This study will assess the efficacy of two local anesthetics (2% lidocaine 1:100,000 epinephrine and 0.5% bupivicaine 1:200,000 epinephrine) in reducing post-operative pain in patients receiving endodontic treatment.
What is the current status of trial NCT05338671?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2021-09-29. Estimated completion is 2024-06-01.
What conditions does trial NCT05338671 study?
This clinical trial studies the following conditions: Postoperative Pain, Endodontic Disease, Symptomatic Irreversible Pulpitis.
What interventions are being tested in trial NCT05338671?
The interventions under investigation include: Local anesthetic (DRUG).
Who is sponsoring clinical trial NCT05338671?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05338671 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05338671's enrollment target sits among peer trials
35 113th of 120 higher than 8 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
QL Block in Laparoscopic Myomectomy
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI